Table 2.
Demographic Variables | JNC7 Guidelinea | 2017 ACC/AHA Guidelinea | Relative % Change Between 2017 ACC/AHA and JNC7 | ||
---|---|---|---|---|---|
% | N (95% CI) | % | N (95% CI) | % | |
Sex | |||||
Men | 26.0 (21.0–31.7) | 544 927 (399 242–690 612) | 47.7 (40.9–54.6) | 998 589 (786 743–1 210 434 | 83.3 |
Women | 32.9 (28.2–37.9) | 871 047 (722 893–1 019 200) | 51.4 (46.0–56.8) | 1 362 486 (1 150 703–1 574 269) | 56.4 |
Age group, y | |||||
20–44 | 9.0 (3.7–19.9) | 40 728 (6580–74 875) | 20.1 (10.4–35.1) | 91 248 (32 866–149 629) | 124.0 |
45–64 | 25.1 (19.1–32.3) | 407 099 (289 526–524 672) | 49.8 (41.6–58.0) | 805 634 (626 508–984 760) | 97.8 |
65–79 | 31.4 (26.0–37.4) | 534 621 (399 670–669 572) | 50.4 (43.6–57.2) | 857 753 (674 005–1 041 501) | 60.4 |
≥80 | 44.8 37.1–52.7 | 443 525 (330 020–537 030) | 62.7 (55.0–69.7) | 606 440 (476 538–736 341) | 36.7 |
Race/ethnicity | |||||
Non‐Hispanic white | 27.6 (23.5–32.1) | 942 220 (740 594–1 143 845) | 48.5 (43.2–53.7) | 1 653 606 (1 344 611–1 962 601) | 75.5 |
Non‐Hispanic black | 40.3 (33.7–47.3) | 269 942 (191 555–348 328) | 58.8 (51.1–66.1) | 393 720 (294 475–492 964) | 45.8 |
Mexican American | 25.6 (16.2–37.7) | 59 304 (28 396–90 213) | 36.8 (25.6–49.5) | 85 371 (50 104–120 637) | 43.9 |
Others | 33.8 (24.1–45.0) | 144 508 (83 131–205 885) | 53.4 (41.2–65.2) | 228 378 (149 611–307 145) | 58.0 |
Total | 29.9 (26.2–33.7) | 1 415 974 (1 191 721–1 640 227) | 49.8 (45.4–54.2) | 2 361 075 (2 035 251–2 686 899) | 66.7 |
ACC/AHA indicates American College of Cardiology/American Heart Association; CI, confidence interval; JNC7, seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; NHANES, National Health and Nutrition Examination Survey.
Represents both hypertension and recommended antihypertensive medication.